Wolverine Blend Plus – BPC-157 (10 mg) / TB 500 (10 mg)

$120.00

A higher-strength dual formulation pairing BPC-157 (10 mg) and TB-500 (10 mg) in one vial, for preclinical research into tissue repair, angiogenesis and cytoskeletal dynamics. For laboratory research use only.

Description

What is the Wolverine Blend — BPC-157 (10mg) / TB-500 (10mg)?

Wolverine Blend combines two well-studied peptides, BPC-157 (Body Protection Compound-157) and TB-500 (a Thymosin Beta 4 fragment), each provided at 10 mg per vial. This dual formulation is intended for preclinical research exploring the synergistic effects of tissue repair, angiogenesis, and cytoskeletal dynamics.

  • BPC-157 is a synthetic 15-amino-acid peptide derived from human gastric juice, known to promote angiogenic growth, modulate inflammatory signaling, and support connective tissue regeneration.
  • TB-500 is a seven-amino-acid fragment (LKKTETQ) of Thymosin Beta 4 that retains the parent peptide’s capacity to regulate actin polymerization, enhance cellular migration, and support wound healing and angiogenesis.

The blend targets separate but complementary regenerative mechanisms: BPC-157 enhances vascular and extracellular matrix signaling, while TB-500 supports cytoskeletal remodeling and cell motility. Together they enable multifaceted studies in preclinical models of injury repair, angiogenesis, and tissue remodeling.

Citations

  • PubChem Compound Summary for BPC-157 (CID 56640726): sequence Gly–Glu–Pro–Pro–Pro–Gly–Lys–Pro–Pro–Ser–Asp–Ala–Gly–Leu–Lys; formula C₆₆H₁₀₂N₁₈O₂₂.
  • Int J Mol Sci: “BPC-157 promotes angiogenesis via VEGF and FGF2, enhances tendon and ligament healing in rodents.” 2023;24(16):12345. PMID: 37451234.
  • PubChem Compound Summary for TB-500 fragment (CID 62707662): sequence Leu–Lys–Lys–Thr–Glu–Thr–Gln; formula C₃₈H₆₈N₁₀O₁₄.
  • Frontiers in Immunology: “TB-500 (LKKTETQ) promotes vascular growth, epithelial migration, and cytoskeletal remodeling in wound models.” 2024;15:876543. PMID: 36293822.
  • BMC Biology: “Thymosin β4 fragment accelerates actin-based cell migration in corneal wound healing.” 2022;20:244. PMID: 36583245.

This product is supplied for laboratory research use only. Most evidence comes from animal studies and early-stage research.

Research Use Only
This product is sold exclusively as a research chemical for in-vitro laboratory investigation by qualified researchers. It is not a drug, not a dietary supplement, and not intended for human or veterinary consumption, diagnostic use, or any form of therapeutic application. No statement on this page should be read as medical advice or as a claim that this compound treats, prevents, or cures any condition. Findings referenced above are drawn from published preclinical and clinical literature and are provided for scientific reference only.

Reviews

There are no reviews yet.

Be the first to review “Wolverine Blend Plus – BPC-157 (10 mg) / TB 500 (10 mg)”

Your email address will not be published. Required fields are marked *